Araceli Biosciences Unveils New Cutting-Edge Headquarters to Fuel Scientific Innovation and Growth

Araceli Biosciences, a leading biotechnology company, has announced its relocation to a new, larger headquarters location to accommodate expanding operations and better serve customers.

Written byAraceli Biosciences
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Araceli will be moving to Tech Center Drive in Tigard, OR, located near the intersection of Interstate 5 and Route 217. Araceli’s new space significantly expands its footprint compared to its current location in Hillsboro, OR. The new location in Tigard is closer to the growing biotech community in the Portland area, and provides ample space for Araceli Biosciences to grow and expand research and manufacturing capacity to meet rising demand.

The move is a significant milestone for the company, which has experienced rapid growth in its first two years in operation. Araceli Biosciences is at the forefront of developing innovative solutions for life science research, high throughput screening and phenotypic drug discovery. Its cutting-edge technologies leveraging AI and machine learning are widely recognized and adopted in the research market.

“We are thrilled to move into our new headquarters and to have the opportunity to expand our operations,” said Jeff Harris, General Manager of Araceli Biosciences. “This move will allow us to better serve our customers and to continue our mission of advancing scientific research through the development of innovative technologies.”

The new location features state-of-the-art laboratory and manufacturing facilities as well as spacious office areas for Araceli Biosciences’ growing team of researchers, data scientists, engineers, and support staff. The facility is designed to foster collaboration, innovation, and productivity, and is a testament to Araceli Biosciences’ commitment to excellence in research and development.

Araceli Biosciences’ new headquarters location will open for business in March 2023, and the company invites its customers, partners, and stakeholders to visit the facility and learn more about its exciting research and development initiatives.

Is the form not loading? If you use an ad blocker or browser privacy features, try turning them off and refresh the page.

You might also be interested in...
Loading Next Article...
You might also be interested in...
Loading Next Article...
July Digest 2025
July 2025, Issue 1

What Causes an Earworm?

Memory-enhancing neural networks may also drive involuntary musical loops in the brain.

View this Issue
Genome Modeling and Design: From the Molecular to Genome Scale

Genome Modeling and Design: From the Molecular to Genome Scale

Twist Bio 
Screening 3D Brain Cell Cultures for Drug Discovery

Screening 3D Brain Cell Cultures for Drug Discovery

DNA and pills, conceptual illustration of the relationship between genetics and therapeutic development

Multiplexing PCR Technologies for Biopharmaceutical Research

Thermo Fisher Logo
Discover how to streamline tumor-infiltrating lymphocyte production.

Producing Tumor-infiltrating Lymphocyte Therapeutics

cytiva logo

Products

The Scientist Placeholder Image

Sino Biological Sets New Industry Standard with ProPure Endotoxin-Free Proteins made in the USA

sartorius-logo

Introducing the iQue 5 HTS Platform: Empowering Scientists  with Unbeatable Speed and Flexibility for High Throughput Screening by Cytometry

parse_logo

Vanderbilt Selects Parse Biosciences GigaLab to Generate Atlas of Early Neutralizing Antibodies to Measles, Mumps, and Rubella

shiftbioscience

Shift Bioscience proposes improved ranking system for virtual cell models to accelerate gene target discovery